182 related articles for article (PubMed ID: 20651054)
1. Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study.
Katz RL; He W; Khanna A; Fernandez RL; Zaidi TM; Krebs M; Caraway NP; Zhang HZ; Jiang F; Spitz MR; Blowers DP; Jimenez CA; Mehran RJ; Swisher SG; Roth JA; Morris JS; Etzel CJ; El-Zein R
Clin Cancer Res; 2010 Aug; 16(15):3976-87. PubMed ID: 20651054
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer.
Feng M; Ye X; Chen B; Zhang J; Lin M; Zhou H; Huang M; Chen Y; Zhu Y; Xiao B; Huang C; Katz RL; Bai C
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2397-2405. PubMed ID: 33547948
[TBL] [Abstract][Full Text] [Related]
3. 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC).
Yendamuri S; Vaporciyan AA; Zaidi T; Feng L; Fernandez R; Bekele NB; Hofstetter WL; Jiang F; Mehran RJ; Rice DC; Spitz MR; Swisher SG; Walsh GL; Roth JA; Katz RL
J Thorac Oncol; 2008 Sep; 3(9):979-84. PubMed ID: 18758299
[TBL] [Abstract][Full Text] [Related]
4. Comparison of molecular abnormalities in bronchial brushings and tumor touch preparations.
Barkan GA; Caraway NP; Jiang F; Zaidi TM; Fernandez R; Vaporcyin A; Morice R; Zhou X; Bekele BN; Katz RL
Cancer; 2005 Feb; 105(1):35-43. PubMed ID: 15605362
[TBL] [Abstract][Full Text] [Related]
5. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
[No Abstract] [Full Text] [Related]
6. Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer.
Tan CL; Lim TH; Lim TKh; Tan DS; Chua YW; Ang MK; Pang B; Lim CT; Takano A; Lim AS; Leong MC; Lim WT
Oncotarget; 2016 Apr; 7(17):23251-62. PubMed ID: 26993609
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer.
Liu WR; Zhang B; Chen C; Li Y; Ye X; Tang DJ; Zhang JC; Ma J; Zhou YL; Fan XJ; Yue DS; Li CG; Zhang H; Ma YC; Huo YS; Zhang ZF; He SY; Wang CL
Thorac Cancer; 2020 Nov; 11(11):3234-3242. PubMed ID: 32989915
[TBL] [Abstract][Full Text] [Related]
8. High frequency of genetic alterations in non-small cell lung cancer detected by multi-target fluorescence in situ hybridization.
Kang JU; Koo SH; Kwon KC; Park JW; Shin SY; Kim JM; Jung SS
J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S47-51. PubMed ID: 17923754
[TBL] [Abstract][Full Text] [Related]
9. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
[TBL] [Abstract][Full Text] [Related]
10. High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer.
Pailler E; Auger N; Lindsay CR; Vielh P; Islas-Morris-Hernandez A; Borget I; Ngo-Camus M; Planchard D; Soria JC; Besse B; Farace F
Ann Oncol; 2015 Jul; 26(7):1408-15. PubMed ID: 25846554
[TBL] [Abstract][Full Text] [Related]
11. Identification of circulating tumor cells using 4-color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low-dose computed tomography-detected lung nodules.
Katz RL; Zaidi TM; Pujara D; Shanbhag ND; Truong D; Patil S; Mehran RJ; El-Zein RA; Shete SS; Kuban JD
Cancer Cytopathol; 2020 Aug; 128(8):553-562. PubMed ID: 32320527
[TBL] [Abstract][Full Text] [Related]
12. EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort.
Varella-Garcia M; Mitsudomi T; Yatabe Y; Kosaka T; Nakajima E; Xavier AC; Skokan M; Zeng C; Franklin WA; Bunn PA; Hirsch FR
J Thorac Oncol; 2009 Mar; 4(3):318-25. PubMed ID: 19247083
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with non-small cell lung cancer.
Li J; Liao Y; Ran Y; Wang G; Wu W; Qiu Y; Liu J; Wen N; Jing T; Wang H; Zhang S
BMC Pulm Med; 2020 Oct; 20(1):274. PubMed ID: 33081780
[TBL] [Abstract][Full Text] [Related]
14. A potential probe set of fluorescence in situ hybridization for detection of lung cancer in bronchial brushing specimens.
Liu YZ; Wang Z; Fang LL; Li L; Cao J; Xu X; Han YL; Cai Y; Wang LX; Wang MR
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1541-9. PubMed ID: 22538453
[TBL] [Abstract][Full Text] [Related]
15. Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy.
Hirsch FR; Herbst RS; Olsen C; Chansky K; Crowley J; Kelly K; Franklin WA; Bunn PA; Varella-Garcia M; Gandara DR
J Clin Oncol; 2008 Jul; 26(20):3351-7. PubMed ID: 18612151
[TBL] [Abstract][Full Text] [Related]
16. The prognostic roles of circulating ALDH1
Tian S; Xing YN; Xia P
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30305380
[TBL] [Abstract][Full Text] [Related]
17. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
[TBL] [Abstract][Full Text] [Related]
18. ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations.
Peretti U; Ferrara R; Pilotto S; Kinspergher S; Caccese M; Santo A; Brunelli M; Caliò A; Carbognin L; Sperduti I; Garassino M; Chilosi M; Scarpa A; Tortora G; Bria E
Respir Res; 2016 Aug; 17(1):105. PubMed ID: 27561692
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization.
Romeo MS; Sokolova IA; Morrison LE; Zeng C; Barón AE; Hirsch FR; Miller YE; Franklin WA; Varella-Garcia M
J Mol Diagn; 2003 May; 5(2):103-12. PubMed ID: 12707375
[TBL] [Abstract][Full Text] [Related]
20. High rate of molecular alteration in histologically tumour-free bronchial epithelium of NSCLC patients detected by multicolour fluorescence in situ hybridisation.
Hilbe W; Auberger J; Dirnhofer S; Schmid T; Erdel M; Duba HC
Oncol Rep; 2006 May; 15(5):1233-40. PubMed ID: 16596192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
